< Back to latest news & events

Event

Technology Transfer Primer – IP Management: AI and 5G in healthcare

December 2021

Event date: 9th December 2021

The University of Hong Kong is hosting a webinar on ‘IP Management: AI and 5G in healthcare’ on 9th December 2021 with HGF’s Partner Dr Chris Benson and Patent Director Dr Sofie McPherson speaking.

About the webinar

How to capitalise on the 5G healthcare revolution

This session will explore how 5G wireless technology will revolutionise the healthcare industry. 5G is promising greater bandwidth, faster speeds and lower latency, and with that, to transform industries including healthcare. Virtual patient care, remote robotic surgery and sharing of 3D medical images for diagnosis of specialists located anywhere across the globe are a few examples of transformative changes to come. 5G will not only enable new healthcare services but also improve the workflow of hospitals and healthcare professionals as they evolve from using wired networks to mobile networks. 5G is also considered to expand the wearables market further as wearables will be able to send and receive far greater amounts of data wirelessly than with 4G, providing the wearers and doctors with real-time monitoring data in volumes that will allow much more powerful insight into an individual’s health status. This session will also explore challenges of 5G in the healthcare industry including how to recognise patentable aspects of 5G implementation in the healthcare sector, data security aspects, and how patent owners of 5G technology can license patents for their technology in vertical markets such as wearables.

Date

9th December, 2021

Time

4pm HK Time/8am UK time

Latest updates

Agritech Thymes: Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

The UK offers an ideal platform for harnessing the untapped potential of soil and plant microorganisms. Although much of my professional experience has focused on the human microbiome, I have …

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Introduction Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

Empowered, Not Replaced: The Risks and Rewards of Using AI Tools in Patent Prosecution

With the rapid rise of AI and extreme hype around generative AI tools in the workplace, patent firms around the world have had to seriously consider to what extent they …

Read article

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article